BDTX-189 manufacturers
- BDTX-189; Tuxobertinib
-
- $0.00 / 100MG
-
2025-01-31
- CAS:2414572-47-5
- Min. Order: 10MG
- Purity: 99% HPLC
- Supply Ability: 10000
- Tuxobertinib
-
- $34.00 / 2mg
-
2024-11-18
- CAS:2414572-47-5
- Min. Order:
- Purity: 98.86%
- Supply Ability: 10g
|
| BDTX-189 Basic information |
Product Name: | BDTX-189 | Synonyms: | BDTX-189;2-Propenamide, N-[4-[[3-chloro-4-(2-pyridinylmethoxy)phenyl]amino]-7-[2-(4-morpholinyl)ethoxy]-6-quinazolinyl]-;Tuxobertinib;Tuxobertinib,inhibit,ErbB-1,EGFR,BDTX 189,BDTX189,mutants,Epidermal growth factor receptor,nude,allosteric,Ba/F3,HER1,oncogene athymic,oral,mice,insertion,Inhibitor;EGFR/HER2 inhibitor BDTX-189;ErbB mutant-specific inhibitor BDTX-189;Tuxobertinib (BDTX-189);Bugatinib | CAS: | 2414572-47-5 | MF: | C29H29ClN6O4 | MW: | 561.03 | EINECS: | | Product Categories: | API;APIs | Mol File: | 2414572-47-5.mol | |
| BDTX-189 Chemical Properties |
Boiling point | 778.0±60.0 °C(Predicted) | density | 1.349±0.06 g/cm3(Predicted) | storage temp. | Store at -20°C | solubility | DMSO:22.56(Max Conc. mg/mL);40.21(Max Conc. mM) DMF:1.0(Max Conc. mg/mL);1.78(Max Conc. mM) DMF:PBS (pH 7.2) (1:2):0.3(Max Conc. mg/mL);0.53(Max Conc. mM) | form | A solid | pka | 12.20±0.43(Predicted) | color | Off-white to light yellow |
| BDTX-189 Usage And Synthesis |
| BDTX-189 Preparation Products And Raw materials |
|